Status: current, Defined. Date: 31-Mar 2018. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4053661000168110 | Olmesartan HCTZ 20/12.5 (Pharmacor) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4053671000168116 | Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | Is a | Olmesartan HCTZ 20/12.5 (Pharmacor) | true | Inferred relationship | Some | ||
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | Is a | olmesartan medoxomil 20 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | ||
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | has unit of use | tablet | true | Inferred relationship | Some | 1652689656 | |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 471822046 | |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 471822046 | |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | has intended active ingredient | olmesartan | true | Inferred relationship | Some | 1652689655 | |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | has Australian BoSS | olmesartan medoxomil | true | Inferred relationship | Some | 1652689655 | |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet, 30 | has TPUU | True | Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | Inferred relationship | Some | 1 |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet, 10 | has TPUU | True | Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | Inferred relationship | Some | 1 |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet, 30, blister pack | has TPUU | True | Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | Inferred relationship | Some | 1 |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet, 10, blister pack | has TPUU | True | Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | Inferred relationship | Some | 1 |
Olmesartan HCTZ 20/12.5 (Pharmacor) tablet, 30, bottle | has TPUU | True | Olmesartan HCTZ 20/12.5 (Pharmacor) tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set